Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

medtech

  • Home
  •  
  • medtech



  • Most Read
  • Latest Comments
  • Uscom hits jackpot with China approval for hypertension monitor
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Uscom hits jackpot with China approval for hypertension monitor
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Uscom hits jackpot with China approval for hypertension monitor
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Uscom hits jackpot with China approval for hypertension monitor
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Uscom hits jackpot with China approval for hypertension monitor
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US
    • News

  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

  • dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    • News

  • Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    • News

  • TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    • News

  • Uscom hits jackpot with China approval for hypertension monitor
    • News

    Uscom hits jackpot with China approval for hypertension monitor

    More than 230 million adults in China suffering from hypertension, a modifiable risk factor, will be able to reduce their risk of heart attack now that medtech company Uscom (ASX: UCM) has had the BP+ device approved for sale by Chinese regulators. Installed on the International Space Station, the BP+ is a patent-protected device that

    Read More
    Public
  • LBT Innovations sets sights on US healthcare market with AI-powered pathology
    • News

    LBT Innovations sets sights on US healthcare market with AI-powered pathology

    Adelaide-based medical technology company LBT Innovations (ASX: LBT) is lining up distributors in the lucrative US healthcare market for their pathology screening tech which is driven by artificial intelligence to maximise testing throughput in labs, providing healthcare professionals with accurate results faster.    The Automated Plate Assessment System (APAS®) is a pathology AI device which automates

    Read More
    Public
  • InteliCare launches aged care remote dashboard to track health of dependants
    • News

    InteliCare launches aged care remote dashboard to track health of dependants

    Continuing to leverage their healthcare technology, InteliCare (ASX: ICR) is furthering its push to give aged care residents privacy and autonomy while ensuring health standards can be maintained where loved ones will be able to track their condition remotely. The launch of InteliLiving health metrics will enable those living independently to have health data uploaded

    Read More
    Public
  • Nuheara receives FDA registration for newest wireless hearing aids
    • News

    Nuheara receives FDA registration for newest wireless hearing aids

    While Americans battle to manage an array of health concerns sweeping the elderly, hearing loss may not be one of them with medtech company Nuheara (ASX: NUH) granted US Food and Drug Administration (FDA) approval for its new wireless hearing aid, IQbuds² PRO. The PRO version expands the Company’s range of wireless, low cost hearing

    Read More
    Public
  • ResApp granted European approval for wearable cough assessment device
    • News

    ResApp granted European approval for wearable cough assessment device

    Amid the growing concerns around coughing in public for the obvious reason, medtech company ResApp Health (ASX: RAP) has secured regulatory approval in Europe for their wearable device that analyses a person’s cough and the medical implications. The device, which is yet to be named, can be easily clipped on to a person’s shirt where

    Read More
    Public
  • MyFiziq inks Tinjoy deal to access 28 million new customers in China
    • News

    MyFiziq inks Tinjoy deal to access 28 million new customers in China

    Health tech company MyFiziq (ASX: MYQ) is making rapid inroads into the lucrative health-conscious Chinese market having signed terms with Tinjoy Biotech to secure direct access to their 28 million consumers. The deal will see MyFiziq’s CompleteScan app integrated with Tinjoy’s WinScan Digital Health Platform where MyFiziq will utilise Tinjoy’s call centre of almost 1,000

    Read More
    Public
  • «
  • ‹
  • 8
  • 9
  • 10
  • 11
  • 12
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.